Physician profile
Eric Todd Moser
NPI 1386664019
$1,370.30
in general payments reported to CMS, 2019-2025
16 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $42.92 · 2022: $107 · 2023: $270 · 2024: $317 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.98 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $290.28 | 2023-2025 | Intellis Adaptivestim, Straightshot, Inceptiv |
| Biogen, INC. | $163.77 | 2023-2025 | Tysabri, Vumerity |
| Medtronic USA, INC. | $143.67 | 2019-2020 | |
| Harmony Biosciences LLC | $134.71 | 2024 | |
| Abbvie INC. | $130.54 | 2023-2025 | |
| Boston Scientific Corporation | $113.56 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $107.00 | 2022 | |
| Argenx US, INC. | $66.75 | 2024-2025 | Vyvgart Hytrulo |
| Vertex Pharmaceuticals Incorporated | $51.48 | 2025 | |
| Eisai INC. | $40.68 | 2025 | |
| Lundbeck LLC | $32.86 | 2023-2024 | Vyepti |
| E.R. Squibb & Sons, L.L.C. | $29.76 | 2020 | |
| Avadel Cns Pharmaceuticals, LLC | $18.87 | 2025 | Lumryz |
| Neurocrine Biosciences, INC. | $18.42 | 2024 | Ingrezza |
| Merz Pharmaceuticals, LLC | $14.44 | 2025 | Xeomin |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.51 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Moser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.